While exploring the molecular mechanism, different immunological analyses and a cre-luciferase assay indicated that by suppressing HDAC2 activity, JRM-28 upregulated the expression and transcriptional activity of CREB not only in mouse primary neurons but also in iPSC-derived human AD neurons. This evidence concerns the gene CREB1 and Alzheimer disease.